HARLEY_CLINIC_GROUP_LTD - Accounts


Company registration number 12821213 (England and Wales)
HARLEY CLINIC GROUP LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
PAGES FOR FILING WITH REGISTRAR
HARLEY CLINIC GROUP LTD
CONTENTS
Page
Statement of financial position
1
Notes to the financial statements
2 - 4
HARLEY CLINIC GROUP LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2023
31 March 2023
- 1 -
2023
2022
Notes
£
£
£
£
Current assets
Debtors
3
87,801
280,646
Cash at bank and in hand
51,598
62,342
139,399
342,988
Creditors: amounts falling due within one year
4
(135,742)
(91,862)
Net current assets
3,657
251,126
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
3,557
251,026
Total equity
3,657
251,126

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 June 2023 and are signed on its behalf by:
R Agha
Director
Company Registration No. 12821213
HARLEY CLINIC GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023
- 2 -
1
Accounting policies
Company information

Harley Clinic Group Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 85 Great Portland Street, London, W1W 7LT.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents amounts receivable for services performed. VAT is not applicable to medical services.

 

Revenue is recognised as services and procedures are completed and billed.

1.3
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.4
Basic financial instruments

Debtors and creditors with no stated interest rate are receivable or payable within one year are recorded at transaction price, Any loss arising from impairment are recognised in the profit and loss account in other administration expenses.

1.5
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

HARLEY CLINIC GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
1
Accounting policies
(Continued)
- 3 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

1.7
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.8
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
2
-
0
3
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
64,499
84,879
Other debtors
23,302
195,767
87,801
280,646
HARLEY CLINIC GROUP LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2023
- 4 -
4
Creditors: amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings
77,275
2,000
Corporation tax
47,620
84,765
Other taxation and social security
1,900
-
0
Other creditors
8,947
5,097
135,742
91,862
5
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
R Agha - Loan
2.00
(1,691)
22,407
(15,520)
5,196
M Agha - Loan
2.00
-
22,406
(15,000)
7,406
(1,691)
44,813
(30,520)
12,602

The advances outstanding at 31 March 2023 were repaid in full, by bank transfer, on 28 May 2023.

6
Parent company

The company's parent is Fortress International Holdings Limited which owns 100% of the issued share capital of the company.

 

The registered office of the parent company is 85 Great Portland Street, London W1W 7LT.

2023-03-312022-04-01false09 June 2023CCH SoftwareCCH Accounts Production 2023.100No description of principal activityR AghaM Agha2023-06-08128212132022-04-012023-03-31128212132023-03-31128212132022-03-3112821213core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3112821213core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3112821213core:CurrentFinancialInstruments2023-03-3112821213core:CurrentFinancialInstruments2022-03-3112821213core:ShareCapital2023-03-3112821213core:ShareCapital2022-03-3112821213core:RetainedEarningsAccumulatedLosses2023-03-3112821213core:RetainedEarningsAccumulatedLosses2022-03-3112821213bus:Director12022-04-012023-03-31128212132021-04-012022-03-3112821213core:WithinOneYear2023-03-3112821213core:WithinOneYear2022-03-3112821213bus:PrivateLimitedCompanyLtd2022-04-012023-03-3112821213bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3112821213bus:FRS1022022-04-012023-03-3112821213bus:AuditExemptWithAccountantsReport2022-04-012023-03-3112821213bus:Director22022-04-012023-03-3112821213bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP